Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 30.30
-0.90 (-2.88%)
At close: Aug 8, 2025
Sage Therapeutics Market Cap
Embla Medical has a market cap or net worth of 12.90 billion as of August 8, 2025. Its market cap has decreased by -0.91% in one year.
Market Cap
12.90B
Enterprise Value
15.92B
Revenue
5.55B
Ranking
n/a
PE Ratio
27.72
Stock Price
$30.30
Market Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 12.90B, an increase of 454.61%. That is a compound annual growth rate of 11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 12.90B | -15.10% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | 20.44B | -7.38% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,372.35B |
| Coloplast | 136.54B |
| Genmab | 88.96B |
| Demant | 54.02B |
| ALK-Abelló | 40.92B |
| H. Lundbeck | 33.40B |
| Ambu A/S | 24.40B |
| Zealand Pharma | 23.11B |